Seres Therapeutics, Inc. Announces Resignation of Michele Trucksis as Executive Vice President and Chief Medical Officer
November 21, 2018 at 07:20 pm IST
Michele Trucksis, Ph.D., M.D. notified Seres Therapeutics, Inc. of her resignation as the Executive Vice President and Chief Medical Officer of the Company. In connection with Dr. Trucksis' resignation, on November 16, 2018, the Company entered into a separation agreement (the Separation Agreement) and a consulting agreement (the Consulting Agreement) with Dr. Trucksis.